Amylyx Pharmaceuticals Inc (AMLX) Stock: A Comprehensive 52-Week Review

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Amylyx Pharmaceuticals Inc’s current trading price is -26.27% away from its 52-week high, while its distance from the 52-week low is 240.32%. The stock’s price range over this period has fluctuated between $1.58 and $7.27. The company, operating within the financial sector, had a trading volume of approximately 2.0 million for the day, which was noticeably higher than the average daily share volume of 0.86 million over the last 3 months.

In terms of market performance, Amylyx Pharmaceuticals Inc had a fairly even. The highest value for the stock in the past year was $7.27 on 11/08/24, and the lowest value was recorded at $1.58 on 06/17/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Amylyx Pharmaceuticals Inc (AMLX) has experienced a quarterly rise of 50.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 477.79M and boasts a workforce of 123 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.86, with a change in price of +1.31. Similarly, Amylyx Pharmaceuticals Inc recorded 865,896 in trading volume during the last 100 days, posting a change of +32.35%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AMLX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

AMLX Stock Stochastic Average

Today’s raw stochastic average for Amylyx Pharmaceuticals Inc over the last 50 days is 92.21%.This indicates a increase from the raw stochastic average of the past 20 days, which was 85.93%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 60.99% and 47.17%, respectively.

AMLX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 41.80%. However, over the past six months, we’ve seen a stronger performance of -5.63%. The price of AMLX fallen by 34.67% over the last 30 days. And in the last five days, it has surged by 16.52%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.